A major functional difference between the mouse and human ARF tumor suppressor proteins

被引:25
作者
Wadhwa, R
Sugihara, T
Hasan, MK
Taira, K
Reddel, RR
Kaul, SC
机构
[1] Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan
[2] Natl Inst Adv Ind Sci & Technol, Gene Funct Res Lab, Tsukuba, Ibaraki 3058566, Japan
[3] Chugai Res Inst Med Sci, Ibaraki 3004101, Japan
[4] Inst Environm Sci, Dept Radiobiol, Kamikita, Aomori 0393212, Japan
[5] Childrens Med Res Inst, Westmead, NSW 2145, Australia
关键词
D O I
10.1074/jbc.M203222200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppression of tumorigenesis is considerably more stringent in the human than in the much shorter lived mouse species, and the reasons for this difference are poorly understood. We investigated functional differences in the control of the ARF (alternative reading frame) protein that acts upstream of p53 and is encoded along with p16(INK4a) at a major tumor suppressor locus in both the human and mouse genomes. The mouse and human ARF proteins are substantially divergent at their carboxyl termini. We have shown that the mouse ARF protein (p19ARF) interacts with Pex19p in the cell cytoplasm leading to its nuclear exclusion and repression of its p53 activation function. The human ARF protein (p14ARF) is substantially smaller than its mouse counterpart and is not subject to this functional inactivation by Pex19p. In an identical cellular background, ribozymes directed against Pex19p enhanced p19ARF- but not p14ARF-activated p53 function. This is the first demonstration of a functional difference between the mouse and human ARF proteins. In view of the major role of ARF in tumor suppression, this distinction may contribute to the different levels of tumor proneness of these species.
引用
收藏
页码:36665 / 36670
页数:6
相关论文
共 54 条
  • [11] Götte K, 1998, MOL CELL BIOL, V18, P616
  • [12] GROWTH SUPPRESSION BY P18, A P16(INK4/MTS1)-RELATED AND P14(INK4B/MTS2)-RELATED CDK6 INHIBITOR, CORRELATES WITH WILD-TYPE PRB FUNCTION
    GUAN, KL
    JENKINS, CW
    LI, Y
    NICHOLS, MA
    WU, XY
    OKEEFE, CL
    MATERA, AG
    XIONG, Y
    [J]. GENES & DEVELOPMENT, 1994, 8 (24) : 2939 - 2952
  • [13] Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
    Honda, R
    Yasuda, H
    [J]. EMBO JOURNAL, 1999, 18 (01) : 22 - 27
  • [14] p16INK4a and the control of cellular proliferative life span -: Commentary
    Huschtscha, LI
    Reddel, RR
    [J]. CARCINOGENESIS, 1999, 20 (06) : 921 - 926
  • [15] Ichimura K, 2000, CANCER RES, V60, P417
  • [16] Iwato M, 2000, CANCER RES, V60, P2113
  • [17] MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
    Jackson, MW
    Lindström, MS
    Berberich, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) : 25336 - 25341
  • [18] James M C, 2000, Prog Cell Cycle Res, V4, P71
  • [19] Kamijo T, 1999, CANCER RES, V59, P2464
  • [20] Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
    Kamijo, T
    Weber, JD
    Zambetti, G
    Zindy, F
    Roussel, MF
    Sherr, CJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8292 - 8297